Bangkok--Jul 4--Aziam Burson-Marsteller
--Trial Expected to Enroll More than 16,000 Volunteers --
Prease briefing will
-Announce the start of the world's largest, community-based, preventive HIV vaccine trial. This trial will be a collaborative effort between the Thai Ministry of Public Health (MoPH) and the U.S. Military HIV Research Program as well as other partners, including Mahidol University, the Royal Thai Army Medical Department, the Henry Jackson Foundation, Aventis Pasteur, VaxGen and the U.S. National Institute of Allergy and Infectious Diseases.
- It will also be the first large-scale trial to test the "prime-boost" vaccine strategy, in which two different types of vaccine are used to gain improved immune response.
- Address the global need to develop preventive AIDS vaccine and the significance of this trial to that end.
SPEAKERS:
- Dr. Vallop Thaineau, Director General, Department of Communicable Disease Control, Thailand Ministry of Public Health
- Dr. Anthony Fauci, Director, National Institute of Allergy and Infectious Diseases (NIAID), U.S.
- Dr. Deborah Birx, Director, U.S. Military HIV Research Program
- Chris Collins, Executive Director, Aids Vaccine Advocacy Coalition (AVAC)
- Sandy Thurman, President, International AIDS Trust
DATE: Monday, 8 July 2002
TIME: 16:00 - 16:45
LOCATION: Barcelona, Spain
For more information:
Foreign journalists, please contact
Dr. Jeremy Plotnick E-mail: [email protected]
or Ms. Sribenja Semmeesook E-mail: [email protected]
Tel 02-2529871 Fax 02-2548353
Thai journalists, please contact
Ms. Duanghatai Buraparat Tel 02-5903338 , 01-6335404 , Fax. 02-5903339 End.
-AN-